1.
Weekly Neoadjuvant Ixabepilone on Surgical Feasibility and Clinical Outcomes in Locally Advanced High-Risk Prostate Cancer: A Phase II Clinical Trial. J. Can. Res. Updates. 2013;2(4): 283-288. doi:10.6000/1929-2279.2013.02.04.6